2020
DOI: 10.1177/1177932220943183
|View full text |Cite
|
Sign up to set email alerts
|

In Silico Investigation of First-Pass Effect on Selected Small Molecule Excipients and Structural Dynamics of P-glycoprotein

Abstract: In this study, the interaction of selected pharmaceutical excipients on the function of P-glycoprotein (P-gp) and activity of 6 cytochrome P450 (CYP) isoforms were computationally investigated. At binding free energy cut-off value of −5.0 kcal/mol, the result showed possible modulatory or inhibitory effect by cethyl alcohol on CPY3A4 and P-gp; cetyltrimethyl-ammonium bromide (CTAB) on CYP1A2 and P-gp; dibutyl sebacate on CYP2C9, CYP2E1, and P-gp; sodium caprylate on CYP1A2 and CYP3A4; while most of the tested … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

0
4
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 7 publications
(4 citation statements)
references
References 75 publications
0
4
0
Order By: Relevance
“…P-glycoprotein (P-gp), a membrane transporter, plays a role in drug absorption and distribution by actively pumping drugs out of cells. P-gp can influence drug bioavailability, and its inhibition or modulation is a consideration in drug development to enhance drug efficacy [25].…”
Section: Discussionmentioning
confidence: 99%
“…P-glycoprotein (P-gp), a membrane transporter, plays a role in drug absorption and distribution by actively pumping drugs out of cells. P-gp can influence drug bioavailability, and its inhibition or modulation is a consideration in drug development to enhance drug efficacy [25].…”
Section: Discussionmentioning
confidence: 99%
“…Permeability glycoprotein (P-gp; ABCB1; MDR1) belongs to the ATP-binding cassette (ABC) superfamily, and it is an active efflux transporter of an extensive range of xenobiotics and endogenous compounds across the cell membrane which requires expenditure of energy in terms of ATP, and it is localized in the gastrointestinal tract, BBB, kidneys, liver, and placenta of humans [ 105 , 106 ]. P-gp efflux and cytochrome P450s (CYPs) activities can greatly impact drug pharmacokinetics by clinically affecting the drug effectiveness, due to the fact that there are more than 55 CYP homologues in humans of which 90% of therapeutic ingredients are metabolized by CYP1A2, CYP2E1, CYP2C19, CYP2C9, CYP2D6, CYP3A5, and/or CYP3A4, [ 106 ]. In the ALS SOD1 G93A mouse model, damages in the BBB and micro-vessels of post-mortem spinal cord and brain tissues have been reported [ 107 ].…”
Section: Discussionmentioning
confidence: 99%
“…Hierarchical clustering builds collectively a hierarchy of clusters based on pairwise compound similarities defined using the atom pair descriptors and the Tanimoto coefficient, and it has application in drug discovery (Sanni et al 2017). Permeability glycoprotein, also known as P-glycoprotein (P-gp; MDR1; ABCB1), is an efflux transporter, which is present in the BBB, GI tract, kidneys, liver, and placenta of humans, where it actively transports a wide range of structurally and mechanistically diverse endogenous compounds and xenobiotics across the cell membrane at the energy expense of ATP hydrolysis (Fatoki et al 2020). P-gp efflux and CYPs activity can profoundly implicate the role of BAPs pharmacokinetics by nutritionally altering their efficacy.…”
Section: Discussionmentioning
confidence: 99%
“…The molecular docking studies were carried out using the selected protein targets that have at least 90% probability and their corresponding ligands based on target prediction results, according to the method of Fatoki et al (2020). Briefly, the target proteins and ligands were prepared for docking, using AutoDock Tools (ADT) v1.5.6 (Morris et al 2009) at default settings, and the output file was saved in pdbqt format.…”
Section: Molecular Docking Studiesmentioning
confidence: 99%